In October 2026, Bayer announced temporary supply disruptions of some medicines in Ukraine. This concerns popular drugs such as Aspirin, AntiFlu, and Nazol.
Reasons for the Medicine Shortage
According to the information provided by the company, the supply issues are related to logistical delays. Bayer confirmed that the shortage is not indicative of a withdrawal of products from the market or a cessation of supplies.
Current Situation in Pharmacies
Currently, according to media reports, Bayer's cardioaspirin is unavailable in pharmacies in Kyiv and several other cities. However, the company assures that the medicines are already on Ukrainian territory and are undergoing necessary regulatory and certification procedures.
Plans for Resuming Supplies
The availability of medicines is expected to be restored in the second half of October. The company urges the public not to panic and assures that the situation will normalize soon.